The short version of IGF-1 fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-08-12. Anything still debated is marked as such rather than presented as settled.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Analog of growth hormone-releasing hormone |
| Amino acid length | 44 residues | Matches the native peptide backbone |
| Molecular weight | Approximately 5135 Da | Calculated from the peptide sequence |
| Receptor target | GHRH receptor | Expressed on pituitary somatotroph cells |
| Primary studied use | Visceral fat reduction | Investigated in HIV-associated lipodystrophy |
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
== Cell Turgor == Pressurized flow of latex has been studied in multiple Asclepias species as a form of defense in addition to the secondary metabolites stored in the latex. In order to augment the defense of the plant some non-articulated laticifer cells contain highly pressurized stores of latex. It has been noted that pressure may be produced by the osmotic uptake of water into the laticifer cell resulting in a turgid cell. When pierced the cell bursts and latex travels quickly through the canal system to stop the herbivore. A desert species, Bursera schlechtendalii, pressurizes the canals right where leaves attach to the stem so that when a grazer eats a leaf latex shoots out. This process is termed the “squirt gun” defense.
=== NIA T32 Training Program for Research Scientists in the Biology of Aging === The NIA T32 Training Program for Research Scientists in the Biology of Aging is one of the nation's premier institutional training programs dedicated to preparing the next generation of leaders in geroscience. Established through support from the National Institute on Aging (NIA), the program provides rigorous multidisciplinary research training for both predoctoral (PhD and MD/PhD) students and postdoctoral fellows pursuing careers in the basic, translational, and clinical biology of aging. For more than three decades, the program has trained investigators who have gone on to become independent scientists, faculty members, and leaders in academia, government, and industry, significantly contributing to advances in aging biology and age-related disease research. The overarching goal of the training program is to develop independent investigators capable of translating discoveries in the fundamental biology of aging into interventions that improve healthspan and reduce the burden of age-associated diseases. Trainees receive individualized, mentor-guided research experiences that integrate molecular, cellular, organismal, and translational approaches to understanding the mechanisms that drive biological aging. The curriculum emphasizes the principles of geroscience—the concept that targeting the biological processes of aging can simultaneously delay or prevent multiple chronic diseases—providing trainees with a broad scientific foundation while encouraging innovative, interdisciplinary research.
The book presented her observations from more than 300 experiments over the span of five years, during which she attempted to discover factors necessary for the preservation of beef, eggs, and other foods. Her work was recommended for royal privilege by fellow chemist Pierre-Joseph Macquer. c. 1775: French explorer, herbalist and botanist Jeanne Baret becomes the first woman to circumnavigate the globe. c. 1775: French chemist, scientific artist and translator, Marie-Anne Paulze Lavoisier began working with her husband chemist Antoine Lavoisier. She was instrumental in the 1789 publication of her husband’s groundbreaking Elementary Treatise on Chemistry, which presented a unified view of chemistry as a field, as she drew diagrams of all the equipment used, and kept strict records that lent validity to the findings. She also translated and critiqued Richard Kirwan's 'Essay on Phlogiston and the Constitution of Acids' which led to the discovery of oxygen gas. 1776: At the University of Bologna, Italian physicist Laura Bassi became the first woman appointed as chair of physics at a university. 1776: German astronomer Christine Kirch received a respectable salary of 400 Thaler for calendar-making. See also her sister Margaretha Kirch 1782–1791: French chemist and mineralogist Claudine Picardet translated more than 800 pages of Swedish, German, English and Italian scientific papers into French, enabling French scientists to better discuss and utilize international research in chemistry, mineralogy and astronomy. c.
Sources: en.wikipedia.org
Gel preparations of calcium gluconate are used to treat hydrofluoric acid burns. The calcium gluconate reacts with hydrofluoric acid to form insoluble, non-toxic calcium fluoride. In addition to a 2.5% calcium gluconate gel being applied directly to the chemical burn, the victim should be provided with oral or injected calcium supplementation because the fluoride ion (F−) precipitates serum calcium and can thus prompt hypocalcemia.
=== Experimental system === Edward George Bowen joined the team after responding to a newspaper advertisement looking for a radio expert. Bowen had previously worked on ionosphere studies under Appleton, and was well acquainted with the basic concepts. He had also used the RRS' RDF systems at Appleton's request and was known to the RRS staff. After a breezy interview, Watson-Watt and Jock Herd stated the job was his if he could sing the Welsh national anthem. He agreed, but only if they would sing the Scottish one in return. They declined, and gave him the job. Starting with the BBC transmitter electronics, but using a new transmitter valve from the Navy, Bowen produced a system that transmitted a 25 kW signal at 6 MHz (50 metre wavelength), sending out 25 μs long pulses 25 times a second. Meanwhile, Wilkins and L.H. Bainbridge-Bell built a receiver based on electronics from Ferranti and one of the RRS CRTs. They decided not to assemble the system at the RRS for secrecy reasons. The team, now consisting of three scientific officers and six assistants, began moving the equipment to Orfordness on 13 May 1935. The receiver and transmitter were set up in old huts left over from World War I artillery experiments, the transmitter antenna was a single dipole strung horizontally between two 75 foot (23 m) poles, and the receiver a similar arrangement of two crossed wires. The system showed little success against aircraft, although echoes from the ionosphere as far as 1,000 miles away were noted.
Dyson also did work in a variety of topics in mathematics, such as topology, analysis, number theory and random matrices. In 1973 the number theorist Hugh Lowell Montgomery was visiting the Institute for Advanced Study and had just made his pair correlation conjecture concerning the distribution of the zeros of the Riemann zeta function. He showed his formula to the mathematician Atle Selberg, who said that it looked like something in mathematical physics and that Montgomery should show it to Dyson, which he did. Dyson recognized the formula as the pair correlation function of the Gaussian unitary ensemble, which physicists have studied extensively. This suggested that there might be an unexpected connection between the distribution of primes (2, 3, 5, 7, 11, ...) and the energy levels in the nuclei of heavy elements such as uranium. Around 1979 Dyson worked with the Institute for Energy Analysis on climate studies. This group, under Alvin Weinberg's direction, pioneered multidisciplinary climate studies, including a strong biology group. Also during the 1970s, Dyson worked on climate studies conducted by the JASON defense advisory group. Dyson retired from the Institute for Advanced Study in 1994. In 1998 he joined the board of the Solar Electric Light Fund. In 2003 he was president of the Space Studies Institute, the space research organization founded by Gerard K. O'Neill; in 2013 he was on its board of trustees. Dyson was a longtime member of the JASON group. Dyson won numerous scientific awards, but never a Nobel Prize.
Sources: en.wikipedia.org
Regarding allegations about the 1 September double tap strike that killed survivors, Sarah Harrison, a former Pentagon legal adviser, told CNN that "They're killing civilians in the first place, and then if you assume they're combatants, it's also unlawful", stating that in the laws covering armed conflict, hors de combat (out of combat) people "no longer able to fight...have to be treated humanely." Experts questioned whether the survivors of the initial explosion could be lawfully targeted, with some describing the allegations about the follow-up strike as potentially constituting an extrajudicial killing. According to these assessments, the legality of the operation depended on whether US forces reasonably believed those targeted remained combatants or posed a continuing threat at the time of the second strike. According to The Guardian, the Trump administration is following a memo from the Office of Legal Counsel that has been "fiercely criticized by outside legal experts" which "says it is permissible for the US to use lethal force against unflagged vessels carrying cocaine since the cartels use the proceeds to fund violence", and by "framing the strikes as specifically targeting the boat ... put the attack on the firmest legal ground". Time magazine reported that experts said the killing of survivors, if true, could be considered murder and a war crime, and that Hegseth could be subject to criminal charges under the Uniform Code of Military Justice, or charged under the US War Crimes Act of 1996.
A small peptide called PapR acts as the effector in the quorum-sensing pathway, and when reimported into the cell, it interacts with PlcR to activate transcription of these virulence genes. When point mutations were introduced into the plcR gene using the CRISPR/Cas9 system, it was observed that the mutated bacteria lost their hemolytic and phospholipase activity. The flagella of B. cereus are encoded by 2 to 5 fla genes, depending on the strain.
Noribogaine, also known as O-desmethylibogaine or 12-hydroxyibogamine, is the principal psychoactive metabolite of the oneirogen ibogaine. It may be involved in the potential antiaddictive effects of ibogaine and ibogaine-containing plant extracts, such as Tabernanthe iboga. The drug appears to have a complex mechanism of action, with many different observed activities. Some of its most potent actions is atypical κ-opioid receptor agonism and serotonin reuptake inhibition. Noribogaine has potent psychoplastogenic effects similarly to ibogaine. Noribogaine was first described in the scientific literature by 1958 and was first identified as a metabolite of ibogaine in 1995. It was first studied in humans in 2015.
Sources: en.wikipedia.org
It is a synthetic analog of growth hormone-releasing hormone, a hypothalamic peptide. It functions as a growth hormone secretagogue acting at pituitary receptors. The classification separates it from direct growth hormone products.
The synthetic peptide incorporates modifications that slow enzymatic breakdown in circulation. Native growth hormone-releasing hormone is short-lived, whereas the analog is designed for greater stability. The core amino acid backbone is largely retained.
The main studied application is reduction of excess visceral abdominal fat in HIV-associated lipodystrophy. Research has measured fat changes through imaging. Findings concern fat distribution rather than overall body weight.
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.